Lab
Albemarle Regional Health Services
Albemarle Regional Health Services was paid $1.92M by Medicaid between Jan 2018 and Dec 2024, across 57 billing codes. Its largest line is 99199, Unlisted special service, procedure or report — 69% of everything it billed.
33Billing provider infoALBEMARLE REGIONAL HEALTH SERVICES
ELIZABETH CITY, NC 27909
ELIZABETH CITY, NC 27909
33aNPI1508942848assigned 10/30/2006
33bProvider typeClinical Medical Laboratory
28Total paid$1.92M
24GClaims286,076
24DCodes billed57
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in North Carolina
Rank by total paid#37 of 128
Median peer was paid$268K
This provider vs. median7.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,225 | $125K | |
| 2019 | 4,015 | $99K | |
| 2020 | 3,247 | $87K | |
| 2021 | 11,611 | $203K | |
| 2022 | 65,572 | $453K | |
| 2023 | 92,293 | $441K | |
| 2024incomplete | 104,113 | $508K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 69% | 262,429 | 182,871 | $1.32M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 2,208 | 1,918 | $178K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.0% | 1,752 | 1,624 | $57K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.9% | 4,183 | 3,591 | $55K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.7% | 464 | 351 | $53K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.9% | 1,534 | 1,355 | $37K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 662 | 603 | $36K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1.4% | 1,850 | 1,731 | $27K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 230 | 209 | $22K |
| 0001A | 1.1% | 392 | 338 | $20K | |
| 0002A | <1% | 334 | 284 | $17K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 169 | 158 | $14K |
45 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 80 | $11K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,048 | $8K |
| 0012A | <1% | 208 | $8K | |
| 0071A | <1% | 142 | $7K | |
| 96127 | <1% | 1,154 | $6K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 340 | $5K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 66 | $5K |
| 0072A | <1% | 93 | $5K | |
| 0011A | <1% | 240 | $4K | |
| 0064A | <1% | 81 | $4K | |
| 81025 | <1% | 496 | $4K | |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 106 | $3K |
| T1002 | Rn services, up to 15 minutes | <1% | 42 | $3K |
| 90734 | <1% | 307 | $2K | |
| D1206 | Topical application of fluoride varnish | <1% | 106 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 454 | $1K |
| 90688 | <1% | 354 | $1K | |
| 90649 | <1% | 20 | $656.80 | |
| 92587 | <1% | 682 | $636.34 | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | <1% | 13 | $500.00 |
| 90715 | <1% | 210 | $478.00 | |
| 90474 | <1% | 25 | $443.30 | |
| 85018 | <1% | 97 | $270.21 | |
| 96160 | <1% | 82 | $253.22 | |
| 90686 | <1% | 524 | $238.99 | |
| 83655 | <1% | 15 | $184.68 | |
| 86592 | <1% | 13 | $70.46 | |
| 87210 | <1% | 12 | $55.29 | |
| 92551 | <1% | 86 | $33.08 | |
| 99173 | <1% | 864 | $1.00 | |
| 90633 | 0% | 79 | $0.00 | |
| 91300 | 0% | 615 | $0.00 | |
| 90670 | 0% | 110 | $0.00 | |
| 90710 | 0% | 16 | $0.00 | |
| 90680 | 0% | 25 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 55 | $0.00 |
| 91301 | 0% | 471 | $0.00 | |
| 90619 | 0% | 62 | $0.00 | |
| 91307 | 0% | 253 | $0.00 | |
| 91306 | 0% | 75 | $0.00 | |
| 90651 | 0% | 64 | $0.00 | |
| 90723 | 0% | 25 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 17 | $0.00 |
| 90696 | 0% | 13 | $0.00 | |
| 90647 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTOOP, ASHLEY (HEALTH DIRECTOR)
Parent organizationALBEMARLE REGIONAL HEALTH SERVICES
| Provider | Location | Paid |
|---|---|---|
| Albemarle Regional Health Services | Elizabeth City, NC | $2.45M |
| Albemarle Regional Health Services | Elizabeth City, NC | $1.11M |
| Albemarle Regional Health Services | Gates, NC | $308K |
| Albemarle Regional Health Services | Edenton, NC | $245K |
| Albemarle Regional Health Services | Windsor, NC | $236K |
| Albemarle Regional Health Services | Hertford, NC | $139K |
| Albemarle Regional Health Services | Camden, NC | $95K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.